BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 15224184)

  • 21. Ubiquitin/proteasome-dependent degradation of D-type cyclins is linked to tumor necrosis factor-induced cell cycle arrest.
    Hu X; Bryington M; Fisher AB; Liang X; Zhang X; Cui D; Datta I; Zuckerman KS
    J Biol Chem; 2002 May; 277(19):16528-37. PubMed ID: 11864973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome.
    Touitou R; Richardson J; Bose S; Nakanishi M; Rivett J; Allday MJ
    EMBO J; 2001 May; 20(10):2367-75. PubMed ID: 11350925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of the 20S proteasome in the degradation of ornithine decarboxylase.
    Bercovich Z; Kahana C
    Eur J Biochem; 1993 Apr; 213(1):205-10. PubMed ID: 8477695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of the proteasome and antizyme in ornithine decarboxylase degradation by a reticulocyte lysate.
    Murakami Y; Matsufuji S; Tanaka K; Ichihara A; Hayashi S
    Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):305-8. PubMed ID: 8216232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of proteasome function prevents thymocyte apoptosis: involvement of ornithine decarboxylase.
    Grassilli E; Benatti F; Dansi P; Giammarioli AM; Malorni W; Franceschi C; Desiderio MA
    Biochem Biophys Res Commun; 1998 Sep; 250(2):293-7. PubMed ID: 9753623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The N terminus of antizyme promotes degradation of heterologous proteins.
    Li X; Stebbins B; Hoffman L; Pratt G; Rechsteiner M; Coffino P
    J Biol Chem; 1996 Feb; 271(8):4441-6. PubMed ID: 8626796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of cellular polyamines by antizyme.
    Coffino P
    Nat Rev Mol Cell Biol; 2001 Mar; 2(3):188-94. PubMed ID: 11265248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endoproteolytic activity of the proteasome.
    Liu CW; Corboy MJ; DeMartino GN; Thomas PJ
    Science; 2003 Jan; 299(5605):408-11. PubMed ID: 12481023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteasomes begin ornithine decarboxylase digestion at the C terminus.
    Zhang M; MacDonald AI; Hoyt MA; Coffino P
    J Biol Chem; 2004 May; 279(20):20959-65. PubMed ID: 15016805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ubiquitin-proteasome pathway of intracellular proteolysis.
    Doherty FJ; Dawson S; Mayer RJ
    Essays Biochem; 2002; 38():51-63. PubMed ID: 12463161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo ubiquitination and proteasome-mediated degradation of p53(1).
    Maki CG; Huibregtse JM; Howley PM
    Cancer Res; 1996 Jun; 56(11):2649-54. PubMed ID: 8653711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feeding the machine: mechanisms of proteasome-catalyzed degradation of ubiquitinated proteins.
    Crews CM
    Curr Opin Chem Biol; 2003 Oct; 7(5):534-9. PubMed ID: 14580555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nitric oxide prevents p21 degradation with the ubiquitin-proteasome pathway in vascular smooth muscle cells.
    Kibbe MR; Nie S; Seol DW; Kovesdi I; Lizonova A; Makaroun M; Billiar TR; Tzeng E
    J Vasc Surg; 2000 Feb; 31(2):364-74. PubMed ID: 10664504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stabilization signals: a novel regulatory mechanism in the ubiquitin/proteasome system.
    Dantuma NP; Masucci MG
    FEBS Lett; 2002 Oct; 529(1):22-6. PubMed ID: 12354607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteasome pathway operates for the degradation of ornithine decarboxylase in intact cells.
    Murakami Y; Tanahashi N; Tanaka K; Omura S; Hayashi S
    Biochem J; 1996 Jul; 317 ( Pt 1)(Pt 1):77-80. PubMed ID: 8694789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural substrates of the proteasome and their recognition by the ubiquitin system.
    Ulrich HD
    Curr Top Microbiol Immunol; 2002; 268():137-74. PubMed ID: 12083004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
    Oncogene; 1999 Jul; 18(30):4313-25. PubMed ID: 10439039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The proteasome-dependent proteolytic system.
    Tanahashi N; Kawahara H; Murakami Y; Tanaka K
    Mol Biol Rep; 1999 Apr; 26(1-2):3-9. PubMed ID: 10363639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct proteasome inhibition by clasto-lactacystin beta-lactone permits the detection of ubiquitinated p21(waf1) in ML-1 cells.
    Fukuchi K; Maruyama H; Takagi Y; Gomi K
    Biochim Biophys Acta; 1999 Aug; 1451(1):206-10. PubMed ID: 10446402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteasome degradation: enter the substrate.
    Förster A; Hill CP
    Trends Cell Biol; 2003 Nov; 13(11):550-3. PubMed ID: 14573346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.